GB

Giri Babu Areti

Active Director Director DIN 02135469
DIN 02135469 First appointment Mar 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2004
Shareholding value •••• Premium profile

About Giri Babu Areti

Data last updated:

Giri Babu Areti is a Director at Midas Biotek Private Limited (since 2004). The company operates in Pharma. Midas Biotek Private Limited reported revenue of ₹1.02 Cr (FY 2025).

DIN 02135469
Primary Designation Director
Industry Pharma
First Appointment 08 Mar 2004
Oldest Company Age 24 yrs
Largest company Midas Biotek Private Limited · ₹1.02 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Midas Biotek Private Limited U01119TG2001PTC038042
Director08 Mar 20042001₹1.02 Cr (FY 2025)Active

Board colleagues of Giri Babu Areti

Directorship timeline

Open interactive timeline →
Midas Biotek Private Limited
Premium access

Shareholding and investment profile for Giri Babu Areti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Giri Babu Areti

Giri Babu Areti currently holds 1 directorship: Midas Biotek Private Limited (Director, since 08 Mar 2004, revenue ₹1.02 Cr (FY 2025)).

Giri Babu Areti was first appointed on 08 Mar 2004 as Director at Midas Biotek Private Limited.

The current boards of Giri Babu Areti's companies include Hari Krishna Chikoti (Midas Biotek Private Limited), Krishna Pulluri (Midas Biotek Private Limited), Srinivas Mukka (Midas Biotek Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available